Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer

Method for semi-automated microscopy of filtration-enriched circulating tumor cells

(2016) Emma Pailler et al.   BMC CANCER

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

(2016) Archana Anantharaman et al.   BMC CANCER

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)

(2016) Galatea Kallergi et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

CTC immune escape mediated by PD-L1

(2016) Xuefei Wang et al.   MEDICAL HYPOTHESES

High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1

(2016) Jennifer L. Schehr et al.   PLoS One

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

(2016) Chiara Nicolazzo et al.   Scientific Reports

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

(2015) E. Pailler et al.   ANNALS OF ONCOLOGY

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

(2015) Z. Cierna et al.   ANNALS OF ONCOLOGY

Frequent expression of PD-L1 on circulating breast cancer cells

(2015) Martine Mazel et al.   Molecular Oncology

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

(2015) Yanna Tang et al.   Oncotarget

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

(2015) Sofia Agelaki et al.   PLoS One

High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma

(2015) Yueh-Min Lin et al.   PLoS One

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

(2014) Maria A Papadaki et al.   BMC CANCER

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

(2014) A D'Incecco et al.   BRITISH JOURNAL OF CANCER

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib

(2014) Antonia Kalykaki et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

(2013) N Xenidis et al.   BRITISH JOURNAL OF CANCER

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

(2012) V. Georgoulias et al.   ANNALS OF ONCOLOGY

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

(2011) F Farace et al.   BRITISH JOURNAL OF CANCER

Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

(2011) V. Hofman et al.   CYTOPATHOLOGY

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

(2011) Matthew G. Krebs et al.   Journal of Thoracic Oncology

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

(2010) Véronique Hofman et al.   INTERNATIONAL JOURNAL OF CANCER

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology

Systemic Spread Is an Early Step in Breast Cancer

(2008) Yves Hüsemann et al.   CANCER CELL

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

(2008) M. Ignatiadis et al.   CLINICAL CANCER RESEARCH

Circulating Tumor Cells and Bone Marrow Micrometastasis

(2008) C. Alix-Panabieres et al.   CLINICAL CANCER RESEARCH

CANCER: The Metastasis Cascade

(2008) C. A. Klein   SCIENCE